THEMIS MEDICARE LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 220.4 INR | -2.33% |
|
+6.27% | +3.52% |
| Feb. 10 | Themis Medicare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
| 2023 | Themis Medicare Limited Launches REMITHEM | CI |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,101 | 2,722 | 2,205 | 2,575 | 8,585 | 10,735 |
| Enterprise Value (EV) 1 | 5,856 | 3,562 | 3,225 | 3,263 | 9,180 | 11,533 |
| P/E ratio | 45.3 x | -25.3 x | 8.9 x | 7.22 x | 11.8 x | 18.9 x |
| Yield | - | - | 0.73% | 1.53% | 0.54% | 0.43% |
| Capitalization / Revenue | 2.43 x | 1.48 x | 1.09 x | 1.12 x | 2.18 x | 3.03 x |
| EV / Revenue | 2.8 x | 1.94 x | 1.6 x | 1.41 x | 2.33 x | 3.25 x |
| EV / EBITDA | 23.3 x | 156 x | 9.13 x | 6.68 x | 9.69 x | 17.3 x |
| EV / FCF | -35.7 x | -106 x | -12.8 x | 14.7 x | 651 x | -46.8 x |
| FCF Yield | -2.8% | -0.95% | -7.79% | 6.82% | 0.15% | -2.14% |
| Price to Book | 3.02 x | 1.72 x | 1.2 x | 1.18 x | 2.99 x | 3.16 x |
| Nbr of stocks (in thousands) | 91,727 | 91,809 | 91,880 | 91,880 | 92,003 | 92,028 |
| Reference price 2 | 55.61 | 29.64 | 24.00 | 28.03 | 93.32 | 116.6 |
| Announcement Date | 7/17/18 | 8/1/19 | 9/6/20 | 8/25/21 | 8/26/22 | 8/16/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 2,095 | 1,838 | 2,016 | 2,307 | 3,946 | 3,543 |
| EBITDA 1 | 251 | 22.79 | 353.4 | 488.8 | 947.1 | 666.9 |
| EBIT 1 | 176.8 | -57.11 | 273.8 | 409.5 | 861.6 | 569.6 |
| Operating Margin | 8.44% | -3.11% | 13.58% | 17.75% | 21.83% | 16.07% |
| Earnings before Tax (EBT) 1 | 113.4 | -126 | 268.7 | 413.3 | 952.6 | 725.1 |
| Net income 1 | 113 | -107.4 | 247.8 | 357 | 728.8 | 569 |
| Net margin | 5.39% | -5.85% | 12.29% | 15.48% | 18.47% | 16.06% |
| EPS 2 | 1.228 | -1.170 | 2.697 | 3.884 | 7.907 | 6.173 |
| Free Cash Flow 1 | -164 | -33.72 | -251.1 | 222.5 | 14.11 | -246.5 |
| FCF margin | -7.83% | -1.84% | -12.46% | 9.64% | 0.36% | -6.96% |
| FCF Conversion (EBITDA) | - | - | - | 45.51% | 1.49% | - |
| FCF Conversion (Net income) | - | - | - | 62.31% | 1.94% | - |
| Dividend per Share | - | - | 0.1750 | 0.4300 | 0.5000 | 0.5000 |
| Announcement Date | 7/17/18 | 8/1/19 | 9/6/20 | 8/25/21 | 8/26/22 | 8/16/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 755 | 840 | 1,020 | 688 | 595 | 798 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 3.009 x | 36.85 x | 2.886 x | 1.408 x | 0.6278 x | 1.197 x |
| Free Cash Flow 1 | -164 | -33.7 | -251 | 222 | 14.1 | -246 |
| ROE (net income / shareholders' equity) | 6.99% | -6.58% | 14.5% | 17.8% | 28.8% | 18.2% |
| ROA (Net income/ Total Assets) | 3.72% | -1.15% | 5.16% | 7.1% | 13.5% | 7.56% |
| Assets 1 | 3,037 | 9,320 | 4,807 | 5,030 | 5,407 | 7,527 |
| Book Value Per Share 2 | 18.40 | 17.20 | 19.90 | 23.80 | 31.20 | 36.90 |
| Cash Flow per Share 2 | 0.4900 | 0.1900 | 0.3600 | 2.070 | 2.200 | 1.360 |
| Capex 1 | 96.1 | 56.3 | 58.1 | 180 | 206 | 287 |
| Capex / Sales | 4.58% | 3.07% | 2.88% | 7.82% | 5.23% | 8.11% |
| Announcement Date | 7/17/18 | 8/1/19 | 9/6/20 | 8/25/21 | 8/26/22 | 8/16/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +3.52% | 243M | |
| +19.27% | 43.18B | |
| +24.05% | 23.23B | |
| +15.11% | 14.6B | |
| +12.33% | 13.54B | |
| +38.36% | 11.5B | |
| -7.63% | 6.79B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.31B |
- Stock Market
- Equities
- THEMISMED Stock
- Financials Themis Medicare Limited
